Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Introducing a Predictive Score for Successful Treatment Free Remission in Chronic Myeloid Leukemia (CML).

Claudiani S, Metelli S, Kamvar R, Szydlo R, Khan A, Byrne J, Gallipoli P, Bulley SJ, Horne GA, Rothwell K, Copland M, Clark RE, Khorashad JS, Foroni L, Milojkovic D, Apperley JF.

Blood. 2019 Nov 13;134(Supplement_1):26. doi: 10.1182/blood-2019-131500.

PMID:
31724022
2.

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent.

Baccarani M, Iacobucci I, Chiaretti S, Foà' R, Balasubramanian P, Paietta E, Foroni L, Jeromin S, Izzo B, Spinelli O, Varma N, Menif S, Terragna C, Seth T, Bidet A, Coriu D, Lunghi F, Mayer J, Scappini B, Langabeer S, Maier J, Burt E, Candoni A, Albano F, Luppi M, Zupan I, Lion T, Zadro R, di Raimondo F, Popak B, Rege-Cambrin G, Annunziata M, Ayala A, Salinas-Viedma V, Ines Prado A, Milner B, Galimberti S, Janssen J, Polli V, Comba L, Borsellino B, Annibali O, Crugnola M, Passamonti F.

Leukemia. 2019 Oct 8. doi: 10.1038/s41375-019-0591-9. [Epub ahead of print] No abstract available.

PMID:
31595038
3.

A rare cause of ulnar nerve entrapment at the elbow in a patient with leprosy.

de Oliveira AJM, Sterman H, Martins RS, Foroni LH, Siqueira MG.

Autops Case Rep. 2019 Jul 12;9(3):e2019096. doi: 10.4322/acr.2019.096. eCollection 2019 Jul-Sep. No abstract available.

4.

Restoration of shoulder external rotation by means of the infraspinatus muscle reinnervation with a radial nerve branch transfer.

Tavares PL, Siqueira MG, Martins RS, Zaccariotto M, Foroni L, Heise CO, Solla D.

Br J Neurosurg. 2019 Jun 19:1-7. doi: 10.1080/02688697.2019.1630549. [Epub ahead of print]

PMID:
31213096
5.

De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial.

Clark RE, Polydoros F, Apperley JF, Milojkovic D, Rothwell K, Pocock C, Byrne J, de Lavallade H, Osborne W, Robinson L, O'Brien SG, Read L, Foroni L, Copland M.

Lancet Haematol. 2019 Jul;6(7):e375-e383. doi: 10.1016/S2352-3026(19)30094-8. Epub 2019 Jun 12.

PMID:
31201085
6.

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second generation tyrosine kinase inhibitors.

Nteliopoulos G, Bazeos A, Claudiani S, Gerrard G, Curry E, Szydlo R, Alikian M, Foong HE, Nikolakopoulou Z, Loaiza S, Khorashad JS, Milojkovic D, Perrotti D, Gale RP, Foroni L, Apperley JF.

Haematologica. 2019 May 9. pii: haematol.2018.200220. doi: 10.3324/haematol.2018.200220. [Epub ahead of print]

7.

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia.

Claudiani S, Gatenby A, Szydlo R, Nesr G, Abulafia AS, Palanicawandar R, Nteliopoulos G, Khorashad J, Foroni L, Apperley JF, Milojkovic D.

Haematologica. 2019 Nov;104(11):2206-2214. doi: 10.3324/haematol.2018.214809. Epub 2019 Mar 28.

8.

Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genes.

Wang J, Gerrard G, Poskitt B, Dawson K, Trivedi P, Foroni L, El-Bahrawy M.

Pathol Int. 2019 Apr;69(4):193-201. doi: 10.1111/pin.12778. Epub 2019 Feb 27.

PMID:
30811747
9.

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Gall TMH, Gerrard G, Frampton AE, Castellano L, Ahmad R, Habib N, Spalding D, Pai M, Foroni L, Jiao LR.

Oncotarget. 2019 Jan 22;10(7):696-706. doi: 10.18632/oncotarget.26511. eCollection 2019 Jan 22.

10.

Functional outcome of spinal accessory nerve transfer to the suprascapular nerve to restore shoulder function: Results in upper and complete traumatic brachial plexus palsy in adults.

Siqueira MG, Martins RS, Solla D, Faglioni W, Foroni L, Heise CO.

Neurol India. 2019 Jan-Feb;67(Supplement):S77-S81. doi: 10.4103/0028-3886.250708.

11.

[Involvement of hospital pharmacy technician for expanding medication reconciliation process in France: Actors' willingness and opinions].

Duwez M, Valette A, Foroni L, Allenet B.

Ann Pharm Fr. 2019 Mar;77(2):168-177. doi: 10.1016/j.pharma.2018.11.003. Epub 2019 Jan 21. French.

PMID:
30678804
12.

Outcomes from primary surgical reconstruction of neonatal brachial plexus palsy in 104 children.

Siqueira MG, Heise CO, Alencar GC, Martins RS, Foroni L.

Childs Nerv Syst. 2019 Feb;35(2):349-354. doi: 10.1007/s00381-018-04036-5. Epub 2019 Jan 4.

PMID:
30610478
13.

The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.

Austin GM, Knight K, Bell J, Carter A, Heartin E, Watson D, Foroni L, Christmas SE, Polydoros F, Clark RE.

Br J Haematol. 2019 May;185(4):791-793. doi: 10.1111/bjh.15629. Epub 2018 Nov 8. No abstract available.

PMID:
30408160
14.

Recurrent histone mutations in T-cell acute lymphoblastic leukaemia.

Collord G, Martincorena I, Young MD, Foroni L, Bolli N, Stratton MR, Vassiliou GS, Campbell PJ, Behjati S.

Br J Haematol. 2019 Feb;184(4):676-679. doi: 10.1111/bjh.15155. Epub 2018 Mar 30. No abstract available.

15.

Good sensory recovery of the hand in brachial plexus surgery using the intercostobrachial nerve as the donor.

Foroni L, Siqueira MG, Martins RS, Heise CO, Sterman H Neto, Imamura AY.

Arq Neuropsiquiatr. 2017 Nov;75(11):796-800. doi: 10.1590/0004-282X20170148.

16.

Elective amputation of the upper limb is an option in the treatment of traumatic injuries of the brachial plexus?

Siqueira MG, Martins RS, Heise CO, Foroni L.

Arq Neuropsiquiatr. 2017 Sep;75(9):667-670. doi: 10.1590/0004-282X20170096. Review.

17.

The intercostobrachial nerve as a sensory donor for hand reinnervation in brachial plexus reconstruction is a feasible technique and may be useful for restoring sensation.

Foroni L, Siqueira MG, Martins RS, Oliveira GP.

Arq Neuropsiquiatr. 2017 Jul;75(7):439-445. doi: 10.1590/0004-282X20170073.

18.

Distal nerve transfer versus supraclavicular nerve grafting: comparison of elbow flexion outcome in neonatal brachial plexus palsy with C5-C7 involvement.

Heise CO, Siqueira MG, Martins RS, Foroni LH, Sterman-Neto H.

Childs Nerv Syst. 2017 Sep;33(9):1571-1574. doi: 10.1007/s00381-017-3492-0. Epub 2017 Jun 24.

PMID:
28647810
19.

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial.

Clark RE, Polydoros F, Apperley JF, Milojkovic D, Pocock C, Smith G, Byrne JL, de Lavallade H, O'Brien SG, Coffey T, Foroni L, Copland M.

Lancet Haematol. 2017 Jul;4(7):e310-e316. doi: 10.1016/S2352-3026(17)30066-2. Epub 2017 May 26.

20.

Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma.

Degache E, Crochet J, Simon N, Tardieu M, Trabelsi S, Moncourier M, Templier I, Foroni L, Lemoigne A, Pinel N, Gil H, Bouillet L, Leccia MT, Charles J.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e257-e258. doi: 10.1111/jdv.14371. Epub 2017 Jul 19. No abstract available.

PMID:
28557105
21.

E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.

Claudiani S, Apperley JF, Gale RP, Clark R, Szydlo R, Deplano S, Palanicawandar R, Khorashad J, Foroni L, Milojkovic D.

Haematologica. 2017 Aug;102(8):e297-e299. doi: 10.3324/haematol.2017.168740. Epub 2017 May 11. No abstract available.

22.

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.

Alikian M, Gale RP, Apperley JF, Foroni L.

Biomol Detect Quantif. 2017 Feb 14;11:4-20. doi: 10.1016/j.bdq.2017.01.001. eCollection 2017 Mar. Review.

23.

Evaluation of a human anti-mouse antibody rapid test for patients requiring radio-immunodiagnostic.

Lamesa C, Gauchez AS, Mazet R, Foroni L, Fagret D, Desruet MD.

Clin Chem Lab Med. 2017 Oct 26;55(11):e259-e261. doi: 10.1515/cclm-2016-0866. No abstract available.

PMID:
28245183
24.

RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.

Alikian M, Whale AS, Akiki S, Piechocki K, Torrado C, Myint T, Cowen S, Griffiths M, Reid AG, Apperley J, White H, Huggett JF, Foroni L.

Clin Chem. 2017 Feb;63(2):525-531. doi: 10.1373/clinchem.2016.262824. Epub 2016 Dec 15.

25.

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia.

Claudiani S, Apperley JF, Deplano S, Khorashad J, Foroni L, Palanicawandar R, Perry R, Milojkovic D.

Am J Hematol. 2016 Nov;91(11):E480-E481. doi: 10.1002/ajh.24495. Epub 2016 Sep 3. No abstract available.

26.

Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia.

Gerrard G, Foong HE, Mudge K, Alikian M, Apperley JF, Foroni L.

Leuk Res. 2016 Oct;49:47-50. doi: 10.1016/j.leukres.2016.08.007. Epub 2016 Aug 13.

PMID:
27552679
27.

The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.

Yasmeen H, Toma S, Killeen N, Hasnain S, Foroni L.

Eur J Med Genet. 2016 Aug;59(8):355-62. doi: 10.1016/j.ejmg.2016.05.016. Epub 2016 Jun 1.

PMID:
27263053
28.

Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.

Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):1023-32. doi: 10.1007/s10096-016-2633-9. Epub 2016 Apr 2.

PMID:
27039341
29.

Compliance with carbapenem guidelines in a university hospital.

Van Hollebeke M, Chapuis C, Bernard S, Foroni L, Stahl JP, Bedouch P, Pavese P.

Med Mal Infect. 2016 Mar;46(2):72-8. doi: 10.1016/j.medmal.2015.10.009. Epub 2016 Feb 10.

PMID:
26874673
30.

The status of epidermal growth factor receptor in borderline ovarian tumours.

Showeil R, Romano C, Valganon M, Lambros M, Trivedi P, Van Noorden S, Sriraksa R, El-Kaffash D, El-Etreby N, Natrajan R, Foroni L, Osborne R, El-Bahrawy M.

Oncotarget. 2016 Mar 1;7(9):10568-77. doi: 10.18632/oncotarget.7257.

31.

Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients.

Alikian M, Ellery P, Forbes M, Gerrard G, Kasperaviciute D, Sosinsky A, Mueller M, Whale AS, Milojkovic D, Apperley J, Huggett JF, Foroni L, Reid AG.

J Mol Diagn. 2016 Mar;18(2):176-89. doi: 10.1016/j.jmoldx.2015.09.005. Epub 2016 Feb 5.

32.

Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.

Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF.

J Infect. 2016 Jan;72(1):103-11. doi: 10.1016/j.jinf.2015.09.041. Epub 2015 Oct 28.

PMID:
26518058
33.

Automated drug dispensing systems in the intensive care unit: a financial analysis.

Chapuis C, Bedouch P, Detavernier M, Durand M, Francony G, Lavagne P, Foroni L, Albaladejo P, Allenet B, Payen JF.

Crit Care. 2015 Sep 9;19:318. doi: 10.1186/s13054-015-1041-3.

34.

Thyroid function abnormalities associated with ponatinib therapy in patients with chronic myeloid leukemia.

Palani R, Apperley JF, Reid A, Foroni L, Deplano S, Milojkovic D.

Thyroid. 2015 Jun;25(6):706-7. doi: 10.1089/thy.2014.0514. Epub 2015 Apr 28. No abstract available.

PMID:
25778107
35.

[In vitro study of the flow duration of antibiotics solutions prepared in elastomeric infusion devices: effect of cold storage for 3 to 7days].

Grangeon-Chapon C, Robein-Dobremez MJ, Pin I, Trouiller P, Allenet B, Foroni L.

Ann Pharm Fr. 2015 Sep;73(5):378-90. doi: 10.1016/j.pharma.2015.01.002. Epub 2015 Feb 24. French.

PMID:
25721763
36.

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

Cross NC, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, Lange T, Lion T, Machova Polakova K, Dulucq S, Martinelli G, Oppliger Leibundgut E, Pallisgaard N, Barbany G, Sacha T, Talmaci R, Izzo B, Saglio G, Pane F, Müller MC, Hochhaus A.

Leukemia. 2015 May;29(5):999-1003. doi: 10.1038/leu.2015.29. Epub 2015 Feb 5. Review.

37.

Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis.

Williams CK, Foroni L, Luzzatto L, Saliu I, Levine A, Greaves MF.

Ecancermedicalscience. 2014 Nov 6;8:478. doi: 10.3332/ecancer.2014.478. eCollection 2014.

38.

PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.

Alonso-Dominguez JM, Grinfeld J, Alikian M, Marin D, Reid A, Daghistani M, Hedgley C, O'Brien S, Clark RE, Apperley J, Foroni L, Gerrard G.

Am J Hematol. 2015 Jan;90(1):20-6. doi: 10.1002/ajh.23857. Epub 2014 Oct 18.

39.

Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia.

Davies A, Giannoudis A, Zhang JE, Austin G, Wang L, Holyoake TL, Müller MC, Foroni L, Kottaridis PD, Pirmohamed M, Clark RE.

Clin Pharmacol Ther. 2014 Dec;96(6):694-703. doi: 10.1038/clpt.2014.176. Epub 2014 Sep 4.

PMID:
25188725
40.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikienė E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedéu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajič T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VH, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Müller MC, Hochhaus A, Schimmel H, Cross NC, Emons H.

Leukemia. 2015 Feb;29(2):369-76. doi: 10.1038/leu.2014.217. Epub 2014 Jul 18.

41.

[Adequacy of antifungal agents in a teaching hospital: too many inappropriate prescriptions despite training].

Fabien L, Foroni L, Brion JP, Maubon D, Stahl JP, Pavese P.

Presse Med. 2014 Sep;43(9):e241-50. doi: 10.1016/j.lpm.2013.11.029. Epub 2014 Jun 24. French.

PMID:
24972851
42.

Real-time quantification assay to monitor BCR-ABL1 transcripts in chronic myeloid leukemia.

Foskett P, Gerrard G, Foroni L.

Methods Mol Biol. 2014;1160:115-24. doi: 10.1007/978-1-4939-0733-5_11.

PMID:
24740226
43.

The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.

Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, Taylor GP, Matsuoka M, Bangham CR.

Blood. 2014 Jun 19;123(25):3925-31. doi: 10.1182/blood-2014-02-553602. Epub 2014 Apr 15.

44.

Perineurioma of the posterior interosseous nerve: surgical treatment.

Menéndez DF, Martins RS, Siqueira MG, Silva IA, Cavalcante LB, Falzoni R, Foroni LH, Teixeira MJ.

Arq Neuropsiquiatr. 2013 Nov;71(11):909-10. doi: 10.1590/0004-282X20130140. No abstract available.

45.

The epidemiology of adult traumatic brachial plexus lesions in a large metropolis.

Faglioni W Jr, Siqueira MG, Martins RS, Heise CO, Foroni L.

Acta Neurochir (Wien). 2014 May;156(5):1025-8. doi: 10.1007/s00701-013-1948-x. Epub 2013 Dec 7.

PMID:
24318512
46.

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.

Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR, Lazarus H, Luger SM, Marks DI, McMillan AK, Moorman AV, Patel B, Paietta E, Tallman MS, Goldstone AH.

Blood. 2014 Feb 6;123(6):843-50. doi: 10.1182/blood-2013-09-529008. Epub 2013 Nov 25.

47.

A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.

Grinfeld J, Gerrard G, Alikian M, Alonso-Dominguez J, Ale S, Valgañon M, Nteliopoulos G, White D, Marin D, Hedgley C, O'Brien S, Clark R, Goldman JM, Milojkovic D, Apperley JF, Foroni L.

Br J Haematol. 2013 Dec;163(5):631-9. doi: 10.1111/bjh.12591. Epub 2013 Oct 10.

PMID:
24117365
48.

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.

de Lavallade H, Khoder A, Hart M, Sarvaria A, Sekine T, Alsuliman A, Mielke S, Bazeos A, Stringaris K, Ali S, Milojkovic D, Foroni L, Chaidos A, Cooper N, Gabriel I, Apperley J, Belsey S, Flanagan RJ, Goldman J, Shpall EJ, Kelleher P, Marin D, Rezvani K.

Blood. 2013 Jul 11;122(2):227-38. doi: 10.1182/blood-2012-11-465039. Epub 2013 May 29.

49.

Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemia.

Gerrard G, Valgañón M, Foong HE, Kasperaviciute D, Iskander D, Game L, Müller M, Aitman TJ, Roberts I, de la Fuente J, Foroni L, Karadimitris A.

Br J Haematol. 2013 Aug;162(4):530-6. doi: 10.1111/bjh.12397. Epub 2013 May 30.

PMID:
23718193
50.

Expanded endonasal approach to skull base meningiomas.

Monaco BA, Ramos HF, Gomes MQ, Espirito Santo MP, Foroni L, Sennes LU, Teixeira MJ.

Arq Neuropsiquiatr. 2013 May;71(5):330-1. No abstract available.

Supplemental Content

Loading ...
Support Center